From Proof of Concepts to Impact at Scale

The promise of developing innovative and lucrative therapeutics and diagnostics in shortened timeframes is accelerating the adoption of data-driven R&D.

However, many organizations are finding it difficult to evolve their R&D processes and teams to exploit “Data and AI solutions at scale” to improve R&D effectiveness.

During this LIVE webinar, an expert panel of drug discovery leaders and senior analysts from the industry together with Capgemini specialists share their insights on building and leading a high-performance data-driven drug discovery organization.

If you are a researcher, data scientist, technologist or other decision maker looking to deliver value to your drug discovery organization then join us on the 23rd March for LIVE discussion and Q&A with our panelists from GSK, Frost & Sullivan and Capgemini. More Details

Can’t make the scheduled time? Register and we will send you the recording of the complete webinar.

Kind regards,

Aneta Manningtonova
Head of Marketing
Business Review Webinars
marketingNS@ns-mediagroup.com